These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38196070)

  • 1. Synergistic Glutathione Depletion and STING Activation to Potentiate Dendritic Cell Maturation and Cancer Vaccine Efficacy.
    Liu J; Zhang Y; Yang B; Jia Y; Liu RT; Ding L; Shen Z; Chen X
    Angew Chem Int Ed Engl; 2024 Mar; 63(10):e202318530. PubMed ID: 38196070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orchestrated Cytosolic Delivery of Antigen and Adjuvant by Manganese Ion-Coordinated Nanovaccine for Enhanced Cancer Immunotherapy.
    Gao ZL; Xu W; Zheng SJ; Duan QJ; Liu R; Du JZ
    Nano Lett; 2023 Mar; 23(5):1904-1913. PubMed ID: 36801829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
    Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D
    Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylation of OVA antigen-loaded PLGA nanoparticles enhances DC-targeting for cancer vaccination.
    Chou PY; Lin SY; Wu YN; Shen CY; Sheu MT; Ho HO
    J Control Release; 2022 Nov; 351():970-988. PubMed ID: 36220488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MnO
    Song T; Liao Y; Zuo Q; Liu N; Liu Z
    J Mater Chem B; 2022 May; 10(18):3474-3490. PubMed ID: 35403638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-Conjugated Silica Solid Sphere as Nanovaccine for Cancer Immunotherapy.
    Dong Y; Gao J; Pei M; Wang X; Zhang C; Du Y; Jiang Y
    Int J Nanomedicine; 2020; 15():2685-2697. PubMed ID: 32368049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-adjuvanted nanovaccine for cancer immunotherapy: Role of lysosomal rupture-induced ROS in MHC class I antigen presentation.
    Wang C; Li P; Liu L; Pan H; Li H; Cai L; Ma Y
    Biomaterials; 2016 Feb; 79():88-100. PubMed ID: 26702587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-signaling pathway activation by pH responsive manganese particles for enhanced vaccination.
    Lv X; Huang J; Min J; Wang H; Xu Y; Zhang Z; Zhou X; Wang J; Liu Z; Zhao H
    J Control Release; 2023 May; 357():109-119. PubMed ID: 36738971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MuSyC dosing of adjuvanted cancer vaccines optimizes antitumor responses.
    Taylor D; Meyer CT; Graves D; Sen R; Fu J; Tran E; Mirza B; Rodriguez G; Lang C; Feng H; Quaranta V; Wilson JT; Kim YJ; Korrer MJ
    Front Immunol; 2022; 13():936129. PubMed ID: 36059502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoscale Coordination Polymer Based Nanovaccine for Tumor Immunotherapy.
    Zhao H; Xu J; Li Y; Guan X; Han X; Xu Y; Zhou H; Peng R; Wang J; Liu Z
    ACS Nano; 2019 Nov; 13(11):13127-13135. PubMed ID: 31710460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascophyllan functions as an adjuvant to promote anti-cancer effect by dendritic cell activation.
    Zhang W; Okimura T; Xu L; Zhang L; Oda T; Kwak M; Yu Q; Jin JO
    Oncotarget; 2016 Apr; 7(15):19284-98. PubMed ID: 27008707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
    Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
    Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A homologous-targeting cGAS-STING agonist multimodally activates dendritic cells for enhanced cancer immunotherapy.
    Wang P; Wang Y; Li H; Wang M; Wang Y; Wang X; Ran L; Xin H; Ma J; Tian G; Gao W; Zhang G
    Acta Biomater; 2024 Mar; 177():400-413. PubMed ID: 38336268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists.
    Baljon JJ; Kwiatkowski AJ; Pagendarm HM; Stone PT; Kumar A; Bharti V; Schulman JA; Becker KW; Roth EW; Christov PP; Joyce S; Wilson JT
    ACS Nano; 2024 Mar; 18(9):6845-6862. PubMed ID: 38386282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells.
    Dong H; Wen ZF; Chen L; Zhou N; Liu H; Dong S; Hu HM; Mou Y
    Int J Nanomedicine; 2018; 13():3353-3365. PubMed ID: 29922056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen epitope-TLR7/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy.
    Song H; Su Q; Shi W; Huang P; Zhang C; Zhang C; Liu Q; Wang W
    Acta Biomater; 2022 Mar; 141():398-407. PubMed ID: 35007785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy.
    Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J
    Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy.
    Han HD; Byeon Y; Kang TH; Jung ID; Lee JW; Shin BC; Lee YJ; Sood AK; Park YM
    Int J Nanomedicine; 2016; 11():5729-5742. PubMed ID: 27843314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione-depletion mesoporous organosilica nanoparticles as a self-adjuvant and Co-delivery platform for enhanced cancer immunotherapy.
    Lu Y; Yang Y; Gu Z; Zhang J; Song H; Xiang G; Yu C
    Biomaterials; 2018 Aug; 175():82-92. PubMed ID: 29803106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-adjuvant Astragalus polysaccharide-based nanovaccines for enhanced tumor immunotherapy: a novel delivery system candidate for tumor vaccines.
    Li N; Zhang Y; Han M; Liu T; Wu J; Xiong Y; Fan Y; Ye F; Jin B; Zhang Y; Sun G; Sun X; Dong Z
    Sci China Life Sci; 2024 Apr; 67(4):680-697. PubMed ID: 38206438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.